Creative Planning’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-85,626
| Closed | -$2.13M | – | 4421 |
|
|
2026
Q2 | $2.13M | Buy |
85,626
+15,893
| +23% | +$372K | ﹤0.01% | 2034 |
|
|
2026
Q1 | $977K | Buy |
69,733
+4,849
| +7% | +$65.3K | ﹤0.01% | 2489 |
|
|
2025
Q4 | $729K | Sell |
64,884
-27,153
| -30% | -$311K | ﹤0.01% | 2531 |
|
|
2025
Q3 | $1.06M | Buy |
92,037
+56,756
| +161% | +$665K | ﹤0.01% | 2053 |
|
|
2025
Q2 | $432K | Buy |
35,281
+23,745
| +206% | +$299K | ﹤0.01% | 2600 |
|
|
2025
Q1 | $165K | Buy |
11,536
+9,743
| +543% | +$152K | ﹤0.01% | 3138 |
|
|
2024
Q4 | $28.5K | Buy |
+1,793
| New | +$35.5K | ﹤0.01% | 3302 |
|
|
2023
Q4 | – | Sell |
-251
| Closed | -$5.08K | – | 2773 |
|
|
2023
Q3 | $5.08K | Buy |
+251
| New | +$5.69K | ﹤0.01% | 2714 |
|
|
2022
Q2 | – | Sell |
-30
| Closed | -$1K | – | 2289 |
|
|
2022
Q1 | $1K | Buy |
+30
| New | +$966 | ﹤0.01% | 2315 |
|
|
2018
Q4 | – | Sell |
-4,252
| Closed | -$291K | – | 1959 |
|
|
2018
Q3 | $291K | Sell |
4,252
-1
| -0% | -$64 | ﹤0.01% | 1420 |
|
|
2018
Q2 | $243K | Sell |
4,253
-502
| -11% | -$26.5K | ﹤0.01% | 1501 |
|
|
2018
Q1 | $219K | Sell |
4,755
-139
| -3% | -$6.6K | ﹤0.01% | 1548 |
|
|
2017
Q4 | $226K | Sell |
4,894
-824
| -14% | -$37.9K | ﹤0.01% | 1519 |
|
|
2017
Q3 | $257K | Sell |
5,718
-183
| -3% | -$7.81K | ﹤0.01% | 1436 |
|
|
2017
Q2 | $232K | Buy |
5,901
+222
| +4% | +$8.39K | ﹤0.01% | 1432 |
|
|
2017
Q1 | $216K | Buy |
5,679
+830
| +17% | +$32.3K | ﹤0.01% | 1436 |
|
|
2016
Q4 | $179K | Buy |
4,849
+253
| +6% | +$9.04K | ﹤0.01% | 1461 |
|
|
2016
Q3 | $159K | Sell |
4,596
-80
| -2% | -$2.8K | ﹤0.01% | 1542 |
|
|
2016
Q2 | $152K | Sell |
4,676
-242
| -5% | -$7.41K | ﹤0.01% | 1408 |
|
|
2016
Q1 | $141K | Sell |
4,918
-1,167
| -19% | -$31.1K | ﹤0.01% | 1418 |
|
|
2015
Q4 | $203K | Buy |
6,085
+1,740
| +40% | +$54.1K | ﹤0.01% | 1189 |
|
|
2015
Q3 | $124K | Buy |
+4,345
| New | +$152K | ﹤0.01% | 1468 |
|
|
2015
Q2 | – | Sell |
-8,524
| Closed | -$419K | – | 1239 |
|
|
2015
Q1 | $419K | Buy |
8,524
+4,086
| +92% | +$189K | ﹤0.01% | 813 |
|
|
2014
Q4 | $202K | Buy |
+4,438
| New | +$174K | ﹤0.01% | 1131 |
|
Other funds holding AVNS
Creative Planning's AVNS Position: Q3 2026 in Review
Creative Planning sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 85,626 shares — an estimated $2.13M sold.
Creative Planning first reported a position in AVNS in Q4 2014 and held it in 24 quarters. The position peaked at $2.13M in Q2 2026. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.
- Creative Planning reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
- Creative Planning sold 85,626 Avanos Medical shares in Q3 2026, an estimated $2.13M.
- Creative Planning first reported a position in Avanos Medical in Q4 2014 and held it in 24 quarters.
- Creative Planning's Avanos Medical position peaked at $2.13M in Q2 2026.
- 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.
Based on Creative Planning's 13F filing for Q3 2026, filed 2 Nov 2026.